REQUEST A DEMO
Total
USD $0.00
Search more companies

Gazolina-Med Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Masonry Contractors | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Hotels (except Casino Hotels) and Motels
Full name: Gazolina-Med Sp. z o.o. Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Gazolina-Med Sp. z o.o. is an enterprise in Poland, with the main office in Kisielice. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on September 28, 2020. There was a net sales revenue increase of 29.36% reported in Gazolina-Med Sp. z o.o.’s latest financial highlights for 2025. Over the same period, its total assets grew by 155.9%. The enterprise’s net profit margin increased by 154% in 2025.

Headquarters
Ul. Jagiellonska 7
Kisielice; Warminsko-Mazurskie; Postal Code: 14-220

Contact Details: Purchase the Gazolina-Med Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Gazolina-Med Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Gazolina-Med Sp. z o.o. report to view the information.
Incorporation Date:
September 28, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
92%
Company Performance
Financial values in the chart are available after Gazolina-Med Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
29.36%
Total Operating Revenue
27.94%
Operating Profit
39.97%
EBITDA
39.97%
Net Profit/Loss for the Period
39.97%
Total Assets
155.9%
Total Equity
23.36%
Operating Profit Margin
154%
Net Profit Margin
154%
Return on Equity (ROE)
-25.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?